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H1N1 influenza A virus can affect the immune system, caus-
ing lymphopenia. This might be of great concern for HIV indi-
viduals undergoing effective antireroviral therapy (cART). We 
report the first confirmed case of H1N1-induced AIDS and 
Pneumocystis jiroveci pneumonia in an HIV-positive woman on 
effective cART since 2006.
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CASE REPORT
A 53-year-old HIV-positive woman was admitted to the emer-
gency department of the Policlinico di Modena for a rapid 
onset of dyspnea, nonproductive cough, frontal and retro-or-
bital headache, fatigue, malaise, myalgia, and fever that started 
3 days before and worsened within the last 24 hours.
On medical history, she had HIV infection, diagnosed in 
1988 (Centers for Disease Control and Prevention = C3), and 
Pneumocistis jiroveci pneumonia (PJP), and she had been 
on combination antireroviral therapy (cART) with abacavir 
600  mg/lamivudine 300  mg and atazanavir 300  mg/ritonavir 
100 mg since 2006. At her last HIV visit, 2 months before hos-
pital admission, she had a CD4+ cell count of 876 cells/mm3, a 
CD4 of 35.6%, and and undetectable HIV viral load (<40 cop-
ies/uL). She also reported former intravenous drug use (IDU) 
and current methadone therapy 50 mg/d, and she was an active 
heavy smoker (30 pack-years). Reverse transcription poly-
merase chain reaction (RT-PCR) on sputum and nasal swab at 
admission were performed. They were both positive for influ-
enza A H1N1, and oseltamivir therapy (75 mg bid) was started.
After an initial improvement, on day 3 after admission, she 
had an unexpected worsening of her clinical conditions. On 
physical examination, she had bilateral chest wheezing and pha-
ryngeal hyperemia. Routine blood tests showed a white blood 
cell count of 4860/mm3, and arterial hemogas analysis showed 
acidosis (pH 7.30), hypoxia (pO2 40.3 mmHg), and hypercapnia 
(pCO2 52.7 mmHg), and her Lactate dehydrogenase (LDH) was 
503 mg/dL. As mild hypercapnia was consistent with the heavy 
smoking history and prior PJP, the subsequent clinical workup 
focused mainly on hypoxia. She denied any cART interruption, 
but her CD4+ count had dropped to 133 cells/mm3. Her total 
lymphocyte count was 440 cells/mmc, with CD4 of 30.2%, CD8 
of 27%, and CD4/CD8 of >1%. Chest computed tomography 
scan, performed on day 3 after admission, showed a pattern of 
multinodular and interstitial pneumonia (Figure 1). Suspecting 
PJP, intravenous therapy with trimetoprim/sulphametoxazole 
(TMP/SMX 15 mgkg/d of TMP) was empirically started. She 
then underwent bronchoalveolar lavage, and the PJP diag-
nosis was confirmed by a Beta-D-glucan elevation (>523 pg/
mL) and positive immunofluorescence microscopy (IFA) and 
RT-PCR for Pneumocystis jiroveci in bronchoalveolar lavage 
fluid (BALF). On day 6 of her hospital stay, her HIV viral load 
was <40 copies/mL. TMP/SMX was continued for a total of 3 
weeks, and at the end of treatment, her CD4+ cell count was 433 
cell/mm3, her CD4 was 27.3%, and her HIV viral load remained 
undetectable.
 PJP is not a common consequence of influenza A infection 
in HIV/AIDS subjects. Only 1 case has been described, a patient 
on effective cART with an HIV viral load of 56 copies/mL and 
644 CD4+ cell/mm3, with a CD4/CD8 of 0.46 4 months before 
H1N1 infection and consequent PJP. The authors refered to this 
PJP diagnosis as possible due to suggestive clinical findings, ele-
vated LDH, clinical response to related primary therapy, and a 
positive PCR in BALF, but negative traditional staining meth-
ods [1]. Our case describes an immunofluorescence-confirmed 
diagnosis of PJP as a complication of H1N1 influenza–induced 
lymphopenia.
H1N1 is able to infect and induce apoptosis in several cell 
types, such as dendritic cells, macrophages, monocytes, T cells, 
and NK cells [2, 3]. In vitro studies have reported that influenza 
A neuroaminidase may enhance HIV-1 replication, syncytium 
formation, and consequent T-cell CD4+ apoptosis and deple-
tion [2]. It is intriguing to notice that despite lymphopenia is a 
clinical manifestation of H1N1 infection, although another case 
of suspected PJP as a complication of influenza A infection has 
been reported in an HIV-infected individual on effective cART. 
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Thus, the vast majority of people living with HIV with a CD4+ 
T-cell count >500 cell/mmc and undetectable viremia who 
experience H1N1 infection do not develop PJP [4].
In our patient, cigarette smoke and chronic obstructive pul-
monary disease could have played a role in the pathogenesis of 
PJP. Tobacco smoke induces oxidative stress, mucosal inflam-
mation, and impaired mucociliary clearance in the airways and 
affects the production of surfactant proteins A and D [5]. Our 
patient also presented with mild chronic obstructive pulmo-
nary disease but refused to take specific therapy.
As latency is not described in PJP, colonization could have 
played a major role in the pathogenesis of this case [7]. The 
patient presented several risk factors for Pneumocystis jiroveci 
colonization: history of Pneumocystis jiroveci isolation from 
bronchoalveolar fluid at the time of AIDS diagnosis, hard 
smoking habit (30 pack-years), chronic obstructive pulmonary 
disease, and patient-reported daily gardening and hiking activ-
ities [7–9].
In addition, at admission and during her hospital stay, the 
patient did not come into contact with other patients with PJP 
as potential sources of a newly acquired Pneumocystis infection 
[10], In fact, there were no other cases of PJP in the Infectious 
Diseases in-patient unit at the time, and the patient spent the 
first 7 days of her hospital stay in a respiratory isolation room, 
as per hospital protocol (an infection control measure to 
prevent the in-ward spread of H1N1 infection). When respira-
tory isolation was lifted, she was moved to a 2-bed room with 
an immunocompetent patient, and no other cases of PJP were 
reported among other immunosuppressed subjects even after 
our patient’s discharge.
We consequently presume that the patient was colonized 
by Pneuocystis jiroveci at the time of H1N1 infection [7–9]. 
Therefore, the association of both H1N1 and hard smok-
ing on innate alveolar immunity and associated H1N1-
induced T-cell CD4+ and NK-cell depletion at the time of 
Pneumocystis lung colonization might explain this rare case 
of PJP in an immune-reconstituted HIV-positive host on 
effective cART.
This work describes a rare case of PJP after influenza A H1N1 
pneumonia and induced lymphopenia in a hard-smoking HIV 
subject on effective cART with undetectable HIV viral load 
throughout her hospital stay. Our case report underlines the 
importance of influenza vaccination among HIV-positive indi-
viduals and strenghtens the importance of close monitoring 
of CD4+ T-cell count and clinical conditions in HIV-positive 
patients with hard-smoking habits, even on effective cART, pre-
senting with influenza-like signs and symptoms during influ-
enza season.
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Figure 1. High-resolution computed tomography scans of the chest from upper 
to lower lobes showing multiple areas of parenchymal thickening with a ground 
glass appearance and concomitant thickening of the inter- and intralobular septa in 
the upper lobes bilaterally, with several parenchymal consolidations with nodular 
morphology prevalent in the right lower lobar site.
